Diabetes Monitoring Devices Market is set to be invigorated with the launch of the first-ever infusion sets in the European region by Medtronic plc.
Diabetes is among the world's top seven leading causes
of death and injury. Diabetes is primarily responsible for over 1.6 million
deaths per year, as per the World Health Organization (WHO). The monitoring
devices are designed to provide daily information regarding a person's glucose
level, such as peak blood sugar level, total daily peak blood sugar level, and
estimated percentage of normal blood sugar level. These tools are essential to
a person with diabetes who is responsible for their own health care. The
adoption of these diabetes monitoring devices is increased globally due to
rising awareness about maintaining blood sugar levels among diabetic patients.
The ultimate goal of these systems is to allow
individuals with diabetes to monitor their own blood glucose levels as well as
provide the physician with a continuous daily tracking of what their patients
are experiencing. Unwanted glucose peaks (Hypoglycemia or Hyperglycemia) are
considered to have severe consequences, including diabetic ketoacidosis, kidney
injury, vision loss, and cardiovascular disorders. Similarly, a vast portion of
undiagnosed diabetic population in emerging countries is poised to be a
hindering factor in expansion of the diabetes
monitoring devices market.
Increasing diabetes rate along with growing
diabetes-prone geriatric population is fuelling growth of the diabetes
monitoring devices market. As per the World Health Organization (WHO), diabetes
affects about 8.5 percent of adults aged 18 and above or 422 million people
worldwide.
Due to the continuous technical development and early
diagnosis of hypo and hyperglycemic diabetes, the diabetes monitoring devices
market is anticipated to grow even more. The growth in the number of diabetes
patients worldwide is being attributed to the continuously changing lifestyles,
as well as the use of alcohol and tobacco. Furthermore, obesity is one of the
leading causes of diabetes. In July 2020, Dexcom introduced the Dexcom G6 Pro,
a device to develop for easy control of blood sugar for diabetic patients.
On the regional front, North America is exceptionally
accommodating the diabetes monitoring devices market owing to its
well-established healthcare infrastructure. Advancements in technology,
launches of new products, rising obesity rate, and higher treatment costs are
driving the diabetes monitoring devices market in this region. Likewise, favorable
policies for diabetes reimbursement and growing healthcare sector are
stimulating demand for the diabetes monitoring devices market in the Asia
Pacific region.

Comments
Post a Comment